UBS raised Gilead's price target to reflect its increased market size view of the HCV market. Shares are Buy rated.
Over the past few years, Citigroup Inc has been grappling with an unusual problem - how to incur more U.S. taxes. …
Gilead price target raised to $80 from $65 at UBS
Theflyonthewall.com – Wed, Oct 3, 2012 7:05 AM EDTRELATED QUOTES
| Symbol | Price | Change |
|---|---|---|
| GILD | 51.03 | -1.20 |
Related Content
- Analysts' Actions: CIT CVX HOS IHS MCRS
- Safeway asset sale not viewed as catalyst, says …
- Omnicare, Walgreen's should not see margin falloff, …
- Analysts' Actions: BIIB CLMT GPOR ORIG
- Analyst cuts Moody's rating, lifts price targ …
- Analysts' Actions: FCX GME OGE SBNY SCTY
- STOCKS NEWS MALAYSIA-MIDF raises Hartalega price …
Recent Quotes Symbol Price Change % Chg Chart Your most recently viewed tickers will automatically show up here if you type a ticker in the "Enter symbol/company" at the bottom of this module.Recent Quotes News
- Sign-in to view quotes in your portfolios.
Insight: Why Citi wants to rack up U.S. taxesReuters
Trading Center
Today on Yahoo!
1 - 6 of 48
Yahoo! Finance on Facebook
@YahooFinance on Twitter
POLL
Should Silicon Valley companies push back against government surveillance?
Loading...